Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Food

Upside Foods raises $400 million to move towards commercialization

by Matt Blois
April 30, 2022 | A version of this story appeared in Volume 100, Issue 15

 

A plate containinng cultured chicken.
Credit: Upside Foods
Upside Foods was previously known as Memphis Meats.

The cultivated-meat company Upside Foods has raised $400 million to move from R&D to commercialization. The firm expects chicken grown from animal cells to be its first product. Upside plans to build a production facility capable of making tens of millions of kilograms of cell-grown meat. It will also invest in making its supply chain for amino acids, sugars, and vitamins more robust. Investors include the food and ingredient companies Cargill, Givaudan, and Tyson Foods.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.